Who knows? Don't be surprised or disappointed if it goes the other way. Some might have been hoping for a different kind of partnership right now. Patheon gives Trius the ability to go it alone. Again, I wouldn't mind that.
As a very long long...Don't even mention the words "going it alone". Just ask the longs who owned AMRN from 16 plus on FDA approval date to now 5. All in less than two years. The costs of GIA when competing against BP well funded organizations will kill most companies. The best option is your first option. Get approval then sell the company to the highest bidder.
It's actually a production issue... I do not see it affecting the stock price... They have to have it made somewhere...
Other things will push the price up... Like it's uniqueness... and need in the medical establishments. And of course, by other pharma companies.... :)
I call it the "reserve a manufacturing spot agreement"! Nothing really happens much at all unless they get an approval in a territory. Its like buying a ticket to a movie on the internet. Doesn;t mean ya have to go!
Ya see, if buyers don;t believe your willing to GIA, then they will lowball ya in any deal offers! So you create the GIA possibility even if your number one goal is to do a deal by territory or totally! TSRX is playing both sides of the post approval street here!